Savara reports third quarter 2022 financial results and provides business update

Austin, texas--( business wire )--savara inc. (nasdaq: svra), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the third quarter ending september 30, 2022 and provided a business update.

SVRA Ratings Summary

SVRA Quant Ranking